港股異動丨網易低開超10%,Q2營收不及預期,派息減少
網易-S(9999.HK)跳空低開10.63%報127.8港元,股價創2023年12月22日以來新低;隔夜美股市場網易收跌11.17%報82.25美元,折算成港股市場價格為128.99港元/股。網易昨晚公佈業績顯示,二季度營收255億元,雖然同比增長6.1%,但低於預期的261.2億元;二季度毛利潤160億元,同比增長11.6%。基本每股淨利潤0.29美元,非公認會計准則下基本每股淨利潤為0.33美元。另外還值得注意的是,網易派發季度股利0.087美元,較首季的0.099美元及去年同期的0.105美元分別減少12.1%及15.2%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.